Novel Antibody for Chronic Hives Brings Relief in Mid-Stage Trial
Urticaria severity reduced within weeks of treatment
Source: medpagetoday.com
Stay updated with breaking news from Itch Severity Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Urticaria severity reduced within weeks of treatment
The latest indication for the dual inflammatory pathway-targeting biologic expands dupilumab's clinical availability to third chronic skin disease.
Monoclonal antibodies, BTK inhibitor alleviate symptoms when antihistamines fall short
Add-on IL inhibitor to H1-antihistamine offers 'promising, novel treatment option'